Matrix Pharmaceutical, Inc.

Fremont, CA 94555

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $0.0
First Award Date 09/05/91
Most Recent Award Date 04/01/92

Key Personnel

Last Name Name Awards Contact
Luck Edward E Luck 2

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/92 - 03/31/93

Matrix Pharmaceutical, Inc. is currently developing a biologically derived surgical adhesive material (SAM). The SAM (patent pending) is comprised of patient-autologous fibrinogen, thrombin and a fibrous protein. The formulation can be altered to facilitate the use of SAM in a variety of surgical indications. New formulations will be prepared...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/05/91 - 12/31/92

DESCRIPTION: (Adapted from the Applicant's Abstract) The ultimate goal of this project is development of the Therapeutic Implant (TI), a novel intralesional drug delivery system. The TI, a viscous injectable gel, is comprised of a protein carrier matrix, vasoactive tissue modifier and therapeutic agent. The TI delivering 5-FU, referred to as ...